Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Medshine Discovery patents new BCL2/BCL2L1 inhibitors

Oct. 4, 2021

Antibodies targeting glycosylated CD44 synthesized at Go Therapeutics

Oct. 1, 2021

PTGER4 antagonists discovered at Hubei Bio-Pharmaceutical, Humanwell Healthcare

Oct. 1, 2021

Leiden University and collaborators patent monoglyceride lipase inhibitors

Oct. 1, 2021

New antivirals presented by EcoSynth, Transmare Chemie

Oct. 1, 2021

Aston University descibres new antibacterials

Oct. 1, 2021

New CDK12 inhibitors presented by Bayer, Deutsches Krebsforschungszentrum

Sep. 30, 2021

Ennovabio, Shanghai Ennova Biopharmaceutical patent MAP4K1 inhibitors

Sep. 30, 2021

Sironax describes new ferroptosis inhibitors

Sep. 30, 2021

Medshine Discovery identifies new S1PR1 agonists

Sep. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...